People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cadence Neuroscience, Inc. | — | Biotechnology | Series B | $29.0M | $332.6M | 2019 |
Andrew Douglas Firlik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Douglas Firlik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Douglas Harris | 1 | 1 |
| Kevin Douglas Chu | 1 | 1 |
| Kent Leyde | 1 | 1 |
| Gerry Douglas Brunk | 1 | 1 |
| Warren Douglas Sheffield | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.